Table 1.
Class I | |
I | Patients with resting ECG abnormalities, LBBB, > 1 mm ST-depression, paced rhythm, or WPW which prevent accurate interpretation of ECG changes during stress |
II | Patients with a non-conclusive exercise ECG but reasonable exercise tolerance, who do not have a high probability of significant coronary disease and in whom the diagnosis is still in doubt |
Class IIa | |
III | Patients with prior revascularization (PCI or CABG) in whom localization of ischemia is important |
IV | As an alternative to exercise ECG in patients where facilities, costs, and personnel resources allow |
V | As an alternative to exercise ECG in patients with a low pre-test probability of disease such as women with atypical chest pain |
VI | To assess functional severity of intermediate lesions on coronary angiography |
VII | To localize ischemia when planning revascularization options in patients who have already had arteriography |
From: ESC Guidelines on the management of stable angina pectoris: executive summary[3].
Pharmacological stress echocardiography is recommended if the patient is unable to exercise adequately.
ECG: Electrocardiography; WPW: Wolf-Parkinson-White syndrome; LBBB: Left bundle branch block; PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass graft. Class I: Benefits are greater than risks, therefore the procedure should be performed; Class IIa: Benefits are greater than risks, although additional studies are required - it is reasonable to perform the procedure.